Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy
Clinical trial NCT03611426 · COMPLETED
Trial details
- NCT number
- NCT03611426
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2018-12-05
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.